Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center

BACKGROUND: Splenic marginal zone lymphoma (SMZL) is a rare lymphoid B-cell malignant neoplasm with primary involvement of the spleen. It is a chronic disease, of indolent behavior and prolonged survival. However, 25% of cases have higher biological aggressiveness, propensity for histological transf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Cancer
Hauptverfasser: de Pádua Covas Lage, Luís Alberto, dos Santos, Felipe Faganelli Caboclo, Levy, Débora, Moreira, Frederico Rafael, Couto, Samuel Campanelli Freitas, Culler, Hebert Fabrício, de Oliveira Costa, Renata, Rocha, Vanderson, Pereira, Juliana
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2020
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7397612/
https://ncbi.nlm.nih.gov/pubmed/32746790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07204-6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge